Costs and access barriers to ondansetron: A national analysis of Medicare part D and Medicare Advantage plans.

被引：0
|
作者：
Jiang, Changchuan
Liao, Joshua
Hu, Xin
Hong, Arthur S.
Niyogi, Sonali
Mullins, Megan A.
Zheng, Zhiyuan
Han, Xuesong
Nipp, Ryan David
Yabroff, Robin
Shih, Ya-Chen Tina
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Div Hematol & Oncol, Dept Internal Med, Dallas, TX USA
[2] UT Southwestern Med Ctr, Dallas, TX USA
[3] Univ Virginia, Sch Med, Charlottesville, VA USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX USA
[5] Amer Canc Soc, Atlanta, GA USA
[6] Univ Oklahoma, Oklahoma City, OK USA
[7] Amer Canc Soc, Dept Surveillance & Hlth Equity Sci, Kennesaw, GA USA
[8] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23126
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The role of satisfaction and switching costs in Medicare Part D choices
    Han, Jayoung
    Ko, Dong Woo
    Urmie, Julie M.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (02): : 398 - 407
  • [22] Variation in Medicare Part D topical steroid prescription costs
    Faletsky, Adam
    Kassamali, Bina
    Han, Jane J.
    Zhao, Bruce
    LaChance, Avery
    Mostaghimi, Arash
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (04) : 928 - 930
  • [23] Inattention and Switching Costs as Sources of Inertia in Medicare Part D
    Heiss, Florian
    McFadden, Daniel
    Winter, Joachim
    Wuppermann, Amelie
    Zhou, Bo
    AMERICAN ECONOMIC REVIEW, 2021, 111 (09): : 2737 - 2781
  • [24] Health care utilization by medicare advantage beneficiaries in the era of the medicare part D drug benefit coverage gap
    Delate, T.
    Raebel, M. A.
    Ellis, J. L.
    Bayliss, E. A.
    VALUE IN HEALTH, 2008, 11 (03) : A12 - A12
  • [25] The Impact of Medicare Part D on Medication Adherence Among Older Adults Enrolled in Medicare-Advantage Products
    Zhang, Yuting
    Lave, Judith R.
    Donohue, Julie M.
    Fischer, Michael A.
    Chernew, Michael E.
    Newhouse, Joseph P.
    MEDICAL CARE, 2010, 48 (05) : 409 - 417
  • [26] Ethnic Disparities in Medicare Part D Satisfaction and Intention to Switch Plans
    You, Kai
    Strawderman, Robert L.
    Li, Yue
    JOURNAL OF AGING & SOCIAL POLICY, 2017, 29 (04) : 297 - 310
  • [27] Association Between Medicare and FDA Policies and Prior Authorization Requirements for Buprenorphine Products in Medicare Part D Plans
    Mark, Tami L.
    Parish, William
    Zarkin, Gary A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (02): : 166 - 167
  • [28] Access to pharmaceuticals in the post-Medicare Part D era
    Palumbo, Francis B.
    Simoni-Wastila, Linda
    Lavallee, Danielle Chauncey
    Blatt, Lisa
    Mullins, C. Daniel
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2010, 1 (01) : 9 - 14
  • [29] Assessment of national medicare part D estimated annual costs for 2007 and 2008 using a patient cohort
    Walberg, M. P.
    Patel, R. A.
    Amaral, M.
    VALUE IN HEALTH, 2008, 11 (03) : A42 - A43
  • [30] Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D
    DeJong, Colette
    Kazi, Dhruv S.
    Dudley, R. Adams
    Chen, Randi
    Tseng, Chien-Wen
    JAMA CARDIOLOGY, 2019, 4 (08) : 828 - 830
12345